These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 1336492

  • 1. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.
    Tsuda H, Hirohashi S.
    Jpn J Cancer Res; 1992 Nov; 83(11):1184-91. PubMed ID: 1336492
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T.
    Cancer Res; 1992 Oct 01; 52(19):5323-8. PubMed ID: 1327506
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M, Iwasaka T, Matsuo N, Hachisuga T, Mori M, Sugimori H.
    Gynecol Oncol; 1997 Apr 01; 65(1):23-9. PubMed ID: 9103386
    [Abstract] [Full Text] [Related]

  • 7. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.
    Kessis TD, Slebos RJ, Han SM, Shah K, Bosch XF, Muñoz N, Hedrick L, Cho KR.
    Am J Pathol; 1993 Nov 01; 143(5):1398-405. PubMed ID: 8238255
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The state of the p53 gene in human papillomavirus (HPV)-positive and HPV-negative genital precancer lesions and carcinomas as determined by single-strand conformation polymorphism analysis and sequencing.
    Kurvinen K, Tervahauta A, Syrjänen S, Chang F, Syrjänen K.
    Anticancer Res; 1994 Nov 01; 14(1A):177-81. PubMed ID: 8166446
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of p53 inactivation in human cervical cell carcinoma development.
    Miwa K, Miyamoto S, Kato H, Imamura T, Nishida M, Yoshikawa Y, Nagata Y, Wake N.
    Br J Cancer; 1995 Feb 01; 71(2):219-26. PubMed ID: 7841033
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis.
    Naito M, Satake M, Sakai E, Hirano Y, Tsuchida N, Kanzaki H, Ito Y, Mori T.
    Jpn J Cancer Res; 1992 Oct 01; 83(10):1030-6. PubMed ID: 1333465
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.